Breast cancer patients could be spared chemotherapy with new genetic test, study shows

  A Mammaprint microarray showing the biopsy results of low risk (top) and high risk (bottom) breast cancer tumours. Photo: Supplied   It's a gruelling decision every breast cancer patient and their doctor must consider: do we need to start chemotherapy, or could we spare you the ravages of the toxic, yet potentially life-saving treatment?
View More/Source Article